CIK 0001730430 · Large accelerated filer
Kiniksa Pharmaceuticals International, plc
Sign in to watch- Ticker
- KNSA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Entity type
- operating
- EIN
- 981795578
- Phone
- 7814319100
- Business address
- 105 PICCADILLY, SECOND FLOOR, LONDON, United Kingdom, W1J 7NJ
- Former names
- Kiniksa Pharmaceuticals, Ltd.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $78,588,440
- in 8 filings, $78.6M under 10b5-1 plans
Net −$78,588,440. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
- Patel Sanj K −$51.7M CHAIRMAN & CEO sold 42% of stake
- Moat Ross −$9.6M CHIEF OPERATING OFFICER sold 91% of stake
- Paolini John F. −$8.9M CHIEF MEDICAL OFFICER sold 58% of stake
- Megna Michael R −$4.9M CHIEF ACCOUNTING OFFICER sold 80% of stake
- Ragosa Mark −$3.4M CHIEF FINANCIAL OFFICER sold 64% of stake
Reading 59 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-03-09 | Ragosa Mark CHIEF FINANCIAL OFFICER | Sale 10b5-1 | −17,981 | $45.58 | $820K | 30,827 |
| 2026-03-09 | Ragosa Mark CHIEF FINANCIAL OFFICER | Sale 10b5-1 | −18,741 | $46.24 | $867K | 12,086 |
| 2026-03-09 | Ragosa Mark CHIEF FINANCIAL OFFICER | Option exercise · Share Option 10b5-1 | −2,036 | 0 | ||
| 2026-03-09 | Ragosa Mark CHIEF FINANCIAL OFFICER | Option exercise · Share Option 10b5-1 | −10,513 | 18,396 | ||
| 2026-03-09 | Ragosa Mark CHIEF FINANCIAL OFFICER | Option exercise · Share Option 10b5-1 | −13,813 | 19,337 | ||
| 2026-03-09 | Ragosa Mark CHIEF FINANCIAL OFFICER | Option exercise · Share Option 10b5-1 | −10,360 | 22,790 | ||
| 2026-03-02 | Paolini John F. CHIEF MEDICAL OFFICER | Option exercise 10b5-1 | +40,000 | $10.36 | $414K | 101,324 |
| 2026-03-02 | Paolini John F. CHIEF MEDICAL OFFICER | Sale 10b5-1 | −12,063 | $44.20 | $533K | 89,261 |
| 2026-03-02 | Paolini John F. CHIEF MEDICAL OFFICER | Sale 10b5-1 | −22,223 | $44.88 | $997K | 67,038 |
| 2026-03-02 | Paolini John F. CHIEF MEDICAL OFFICER | Sale 10b5-1 | −5,714 | $45.92 | $262K | 61,324 |
| 2026-03-02 | Paolini John F. CHIEF MEDICAL OFFICER | Option exercise · Share Option 10b5-1 | −40,000 | 58,424 | ||
| 2026-02-12 | Quart Barry D Director | Option exercise 10b5-1 | +2,690 | $15.47 | $42K | 15,236 |
| 2026-02-12 | Quart Barry D Director | Sale 10b5-1 | −2,690 | $45.00 | $121K | 12,546 |
| 2026-02-12 | Quart Barry D Director | Option exercise · Share Option 10b5-1 | −2,690 | 0 | ||
| 2026-02-10 | Quart Barry D Director | Option exercise 10b5-1 | +110 | $15.47 | $2K | 12,656 |
| 2026-02-10 | Quart Barry D Director | Sale 10b5-1 | −110 | $45.00 | $5K | 12,546 |
| 2026-02-10 | Quart Barry D Director | Option exercise · Share Option 10b5-1 | −110 | 2,690 | ||
| 2026-02-09 | Ragosa Mark CHIEF FINANCIAL OFFICER | Option exercise 10b5-1 | +8,374 | $12.97 | $109K | 27,460 |
| 2026-02-09 | Ragosa Mark CHIEF FINANCIAL OFFICER | Option exercise 10b5-1 | +2,471 | $16.90 | $42K | 29,931 |
| 2026-02-09 | Ragosa Mark CHIEF FINANCIAL OFFICER | Sale 10b5-1 | −9,114 | $42.85 | $391K | 20,817 |
Page 17 of 74 · 1,467 trades